What is TECHLAB?
TECHLAB, Inc. is a prominent developer and manufacturer specializing in infectious disease diagnostics. Their product portfolio includes tests for critical pathogens such as C. difficile, H. pylori, and foodborne pathogens. Beyond diagnostics, TECHLAB extends its expertise to contract manufacturing and research services for industrial and academic clients, focusing on enhancing laboratory efficiency. The company's commitment to quality is evidenced by its ISO certification and FDA registration, enabling global clinical use of its solutions. TECHLAB's mission is to deliver innovative diagnostic tools for intestinal diseases and other infections.
How much funding has TECHLAB raised?
TECHLAB has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for TECHLAB?
The recent major strategic investment indicates TECHLAB is poised for significant expansion and further product development. This enterprise-level funding is likely to accelerate the company's growth trajectory, potentially enabling market penetration into new territories or the enhancement of its existing diagnostic platforms. The strategic nature of this capital infusion suggests a focus on strengthening its competitive advantage in the infectious disease diagnostics market and potentially exploring new research avenues or strategic partnerships to bolster its service offerings.
See full TECHLAB company page
